Rejuvenate Bio
rejuvenatebio.com
Actively hiring
Cell & Gene Therapy
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$34M
2 rounds on record
Latest round
$19.5M
Venture round · Jun 2026 · 3 mo ago
Team
2
US Form 5500 (plan participants) · Dec 2025 · 0% in a year
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 3
Raised a round Venture round $19.5M · SEC Form D
Feb 14, 2024
Partnership Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis · businesswire.com
Jan 3, 2023
New executive Rejuvenate Bio Appoints Deborah Ascheim, M.D., as Chief Medical Officer · businesswire
Apr 16, 2021
Raised a round Venture round $14.6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jun 2026 | $19.5M | — | SEC Form D |
| Venture round | Apr 2021 | $14.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Rejuvenate Bio Inc | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Daniel OliverExecutive Officer, DirectorSEC Form D
Noah DavidsohnExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our…
Top of page Our Story Fuse Vectors was born from a shared vision to build better viral vectors for gene therapy. Drawing on their industry…
ElevateBio is powering the industry with an integrated approach to technologies and manufacturing.
Neurona is developing cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases.
Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent…
On this page Key figures Home > Who we are > Company Our mission is to turn scientific advances in gene therapy into novel treatments for…
News
Wolfgang Miesbach, MD, PhD, on Future Research with EtranaDez CGTlive
The professor and head of coagulation disorders and Comprehensive Care Centre, University Hospital of Frankfurt, Germany, discussed future integration of EtranaDez into hemophilia B treatment.
Read more
Report
Jetstream Venture Fund Invests In Rejuvenate Bio Alongside Merck
Jetstream Venture Fund announced that it has established an investment interest in Rejuvenate Bio, a biotechnology company focused on gene therapy-based treatments for chronic and age-related diseases.
Read more
Report
Lifespan Portfolio Company Rejuvenate Bio Closes $6 Million Financing and R&D Collaboration with Merck Animal Health
Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, congratulates its portfolio company Rejuvenate Bio on the successful close of a $6 million financing round and the announcement of a strategic resear
Read more
Report
Rejuvenate Bio Raises $6 Million And Partners With Merck Animal Health To Advance Gene Therapy Programs
Rejuvenate Bio, a biotechnology company focused on developing gene therapies for chronic and age-related diseases, announced the closing of a $6 million financing round led by VCapital. Additional participants in the round include Merck Animal Health, Ken
Read more
Report
Daniel Oliver from Rejuvenate Bio to Speak at TechCon SoCal 2026
San Diego, California--(Newsfile Corp. - May 13, 2026) - Rejuvenate Bio is pleased to announce that Daniel Oliver, CEO and Co-Founder of Rejuvenate Bio, will be speaking at TechCon SoCal 2026. This year's event will be held May 22, 23 at the San Diego Sta
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Daniel Oliver
Executive Officer, Director
Noah Davidsohn
Executive Officer, Director
David Zhu
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Diego
United States
HQ
Location
50-200 est. staff
San Diego, CA 92121